Exane Derivatives’s W.R. Berkley WRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6
Closed -$266 1020
2022
Q1
$266 Sell
6
-1
-14% -$40 ﹤0.01% 933
2021
Q4
$247 Hold
7
﹤0.01% 826
2021
Q3
$220 Hold
7
﹤0.01% 1007
2021
Q2
$225 Buy
+7
New +$242 ﹤0.01% 1010
2021
Q1
Sell
-7
Closed -$199 968
2020
Q4
$199 Hold
7
﹤0.01% 796
2020
Q3
$183 Hold
7
﹤0.01% 725
2020
Q2
$172 Hold
7
﹤0.01% 659
2020
Q1
$157 Hold
7
﹤0.01% 666
2019
Q4
$207 Hold
7
﹤0.01% 650
2019
Q3
$217 Hold
7
﹤0.01% 623
2019
Q2
$198 Buy
+7
New +$192 ﹤0.01% 631
2019
Q1
Sell
-7
Closed -$148 715
2018
Q4
$148 Hold
7
﹤0.01% 636
2018
Q3
$160 Hold
7
﹤0.01% 602
2018
Q2
$145 Hold
7
﹤0.01% 597
2018
Q1
$143 Hold
7
﹤0.01% 539
2017
Q4
$143 Buy
+7
New +$143 ﹤0.01% 529
2017
Q3
Sell
-7
Closed -$138 653
2017
Q2
$138 Hold
7
﹤0.01% 556
2017
Q1
$141 Hold
7
﹤0.01% 475
2016
Q4
$133 Hold
7
﹤0.01% 527
2016
Q3
$116 Hold
7
﹤0.01% 528
2016
Q2
$120 Hold
7
﹤0.01% 463
2016
Q1
$112 Buy
+7
New +$108 ﹤0.01% 525
2015
Q4
Sell
-7
Closed -$109 571
2015
Q3
$109 Hold
7
﹤0.01% 489
2015
Q2
$104 Hold
7
﹤0.01% 493
2015
Q1
$101 Sell
7
-11,198
-100% -$166K ﹤0.01% 491
2014
Q4
$170K Buy
+11,205
New +$168K 0.02% 234

Other funds holding WRB

Exane Derivatives's WRB Position: Q2 2022 in Review

Exane Derivatives sold out of W.R. Berkley (WRB) in Q2 2022, closing a stake of 6 shares — an estimated $266 sold.

Exane Derivatives first reported a position in WRB in Q4 2014 and held it in 26 quarters. The position peaked at $170K in Q4 2014. 664 funds tracked by Wall St. Rank hold WRB as of Q2 2022.

  • Exane Derivatives reported no remaining W.R. Berkley position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 6 W.R. Berkley shares in Q2 2022, an estimated $266.
  • Exane Derivatives first reported a position in W.R. Berkley in Q4 2014 and held it in 26 quarters.
  • Exane Derivatives's W.R. Berkley position peaked at $170K in Q4 2014.
  • 664 funds tracked by Wall St. Rank held W.R. Berkley as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.